Qualification
MBBS, MD, DCH, FRCPCH, FRCPath, CCT (UK)Languages
English Kannada Hindi Malayalam TamilWork Experience
18 YearsResearch Experience
Here are some specific examples of Dr. Anoop P's research work:• Novel combination therapy for acute myeloid leukemia (AML): A phase II clinical trial. This study evaluated the safety and efficacy of a novel combination therapy for the treatment of acute myeloid leukemia (AML). The study found that the combination therapy was safe and effective and resulted in a high response rate.
• Targeted therapy for CD20-positive lymphomas: A retrospective analysis of 100 patients. This study evaluated the safety and efficacy of targeted therapy for the treatment of CD20-positive lymphomas. The study found that targeted therapy was a safe and effective treatment modality for this patient population and was associated with improved survival rates.
• Immunotherapy for non-Hodgkin's lymphoma: A single-center retrospective study of 50 patients. This study evaluated the role of immunotherapy in the treatment of non-Hodgkin's lymphoma. The study found that immunotherapy was a safe and effective treatment modality for this patient population and was associated with prolonged remission rates.
• Long-term oncological outcomes and quality of life of patients treated with bone marrow transplantation for hematologic malignancies: A single-center retrospective study of 100 patients. This study investigated the long-term oncological outcomes and quality of life of patients treated with bone marrow transplantation for hematologic malignancies. The study found that bone marrow transplantation was associated with favorable long-term oncological outcomes and quality of life.
Awards & Achivements
Dr. Anoop P is well known in the academic fieldwith over 60 publications in reputed international medical journals indexed by Medline/PubMed. In addition
he is a reviewer for journals such as Hematology
Pediatric Hematology & Oncology
International Journal of Hematology
Indian Pediatrics and Journal of Pediatric Hematology & Oncology. He has presented topics at scientific meetings on lymphoma (Lugano
Switzerland)
leukemia (London
UK)
stem cell mobilisation (Baltimore
USA)
autoimmune hemolytic anemia (Guildford
UK) and clinical trials (Oslo
Norway).
Memberships
He is an active member of many professional bodies including Indian Academy of Pediatrics (IAP)British Society for Hematology (BSH)
Royal College of Pediatrics & Child Health (RCPCH)
Hematology division of the Royal College of Pathologists (RCPath)
European Hematology Association (EHA)
Indian Society of Hematology and Blood Transfusion (ISHBT)
Paediatric Haemato-Oncology Chapter of Indian Academy of Pediatrics (IAP-PHO).
Area of Interest
Haematological cancers in adults and children - leukaemialymphoma
multiple myeloma
myelodysplastic syndromes (MDS)
myeloproliferative disorders (MPD).
Non-malignant (benign) haematological disorders – aplastic anaemia
inherited bone marrow failur